Skip to main content
Commentary: Topical treatments, dupilumab, and long-term treatment of AD, July 2023
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Commentary: Topical treatments, dupilumab, and long-term treatment of AD, July 2023
User login
Username
Password
Reset your password
Concept
Lead
score
Dermatitis
1
1
Thromboembolism
0
1
Monoclonal Antibody
0
0.75
Venous Thromboembolism (VTE)
0
0.74
Microbiology
0
0.65
Adherence
0
0.55
Atopic Dermatitis
0
1
Eczema
0
0.15
Pruritus
0
0.85
Specialty
Lead
score
Dermatology
1
0.52
Family Medicine/Primary Care
0
0.85
Allergy & Clinical Immunology
0
0.35
Edit Tags